Related Experiment Video
Updated: Jan 16, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
A pilot study investigating the impact of cigarette smoking on oral nitrate-reducing bacteria within the oral
Tomas L Nicholas1, Raul Bescos2, Amazon Doble1
1University of Plymouth, Peninsula Dental School, Plymouth PL48AA, UK.
Objective:
To evaluate the impact of cigarette smoke on the activity and abundance of oral nitrate reducing bacteria (ONRB) in vivo and in vitro.
Materials And Methods:
An observational study comprising of eleven cigarette smokers and thirty-one non-smokers. A saliva and nitrate-rinse sample were collected from each participant to analyse salivary biomarkers and the activity and abundance of ONRB in vivo. Additionally, the effect of cigarette smoke on the nitrate-reducing activity of four Rothia species was investigated in vitro.
Results:
The beta diversity of the oral microbiome was significantly different between smokers and non-smokers (P = 0.0063). Neisseria flavescens and Actinomyces oris were significantly higher in the saliva of smokers, however, Neisseria subflava, Neisseria oralis, Kingella denitrificans and Actinomyces georgiae were lower. Salivary nitrite levels were significantly lower in smokers (P = 0.034), along with a trend for decreased salivary pH (P = 0.058) and increased salivary thiocyanate (P = 0.018). In vitro exposure to cigarette smoke decreased the nitrate-reducing activity by Rothia species (P = 0.0046).
Conclusions:
Smoking decreased salivary nitrite levels and had a species dependent effect on ONRB abundance in vivo and inhibitory effect on the nitrate-reducing activity of Rothia species in vitro.
Clinical Significance:
A 'shift' in the oral microbiome and inhibitory effect on nitrate reduction in smokers may contribute to an increased risk of oral and cardiovascular disease. Better understanding of this pathway may have the potential for development of interventions to decrease disease risk in this group.
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...

